The Senior Manager, Value & Access Pipeline is accountable for shaping and executing the Italian affiliate’s early value and access strategy for the products under its responsibility from time to time, ensuring that clinical development choices and evidence-generation plans anticipate and satisfy future Health Technology Assessment (HTA), pricing and reimbursement requirements in Italy. For its products of reference, the role provides strategic input to clinical research and cross-functional teams on endpoints, comparators, biomarkers, unmet medical need and outcomes that are likely to be pivotal for local payer value demonstration. The position also leads local disease-area readiness for emerging therapeutic areas by building robust insight on epidemiology, patient pathways, current standards of care, unmet needs, and access barriers, and translating these insights into affiliate launch readiness actions.
Early Value & Access Strategy & Clinical Development Support
Early strategic support to clinical development to ensure that trial design, endpoints, comparators, and evidence generation are relevant for HTA and reimbursement in Italy.
Emerging Therapeutic Area Intelligence & Affiliate Readiness
Development of deep knowledge of emerging therapeutic areas and preparation of the Italian affiliate in terms of value story, access risks, data needs, and internal capabilities.
Cross-Functional Alignment (Local–EU–Global) & Governance
Coordination and alignment across local, European, and global levels on value and access activities, ensuring strategic consistency, governance, and representation of the Italian perspective.
External Stakeholder Engagement & Insight Generation
Structured and compliant engagement with external stakeholders (HTA bodies, payers, clinicians, KOLs, pharmacists, academia) to gather insights on evidence expectations, access barriers, and implementation.
Evidence Planning (HEOR/RWE), Value Tools & Payer Value Story
Contribution to integrated evidence planning (HEOR/RWE), development of economic models, and value tools supporting pricing and reimbursement decisions.
Minimum Education & Experience Requirements
- Postgraduate qualification (preferred), such as a PhD, MSc in Health Economics/HTA, MBA, or specialized training in outcomes research or evidence generation.
- Minimum of 7 years of progressive experience in Market Access / Value & Access and Pricing & Reimbursement within the pharmaceutical environment, including exposure to pipeline assets (pre-launch).
- Fluency in English, both written and spoken.
- Proven track record of cross-functional leadership in a matrix organization, with effective collaboration with EU and Global teams.
- Experience engaging, either directly or through compliant insight generation, with external stakeholders (payers, HTA experts, clinicians, patient groups) and translating insights into strategic recommendations.
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Top Skills
What We Do
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.
With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
